GGrantIndex
← Leaderboards

Adam Thomas Woolley

Brigham Young University

$5,211,274
Attributed
$9,552,584
Total exposure
3
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200621
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$9,552,584 · 3

By mechanism

R01$9,552,584 · 3

Top collaborators

Most similar at Brigham Young University

Same institution · by research overlap

Others in their field

Top investigators on “Fluorescence

Research focus

FluorescenceMicrofluidicsBlood SpecimenBloodDevicesSamplingLabelDetectionComplexBaseProteinsPerformanceMicrofluidic MicrochipsDiagnosisDesignHealthcareMedicalMicrochip ElectrophoresisSolidMiniaturizeCostMicrochipMembraneBiological Markers

Grant awards (20)

3D-Printed Integrated Microfluidic Devices for Preterm Birth Biomarker Analysis$255,192
R01 · FY2021 · EB · contact PI
3D-Printed Integrated Microfluidic Devices for Preterm Birth Biomarker Analysis$260,400
R01 · FY2020 · EB · contact PI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$982,407
R01 · FY2019 · AI
3D-Printed Integrated Microfluidic Devices for Preterm Birth Biomarker Analysis$280,400
R01 · FY2019 · EB · contact PI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$988,510
R01 · FY2018 · AI
3D-Printed Integrated Microfluidic Devices for Preterm Birth Biomarker Analysis$270,400
R01 · FY2018 · EB · contact PI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$1,002,828
R01 · FY2017 · AI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$1,069,803
R01 · FY2016 · AI
Integrated microfluidic devices for preterm birth biomarker measurement$297,675
R01 · FY2016 · EB · contact PI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$1,383,090
R01 · FY2015 · AI
Integrated microfluidic devices for preterm birth biomarker measurement$291,721
R01 · FY2015 · EB · contact PI
Integrated microfluidic devices for preterm birth biomarker measurement$288,745
R01 · FY2014 · EB · contact PI
Integrated microfluidic devices for preterm birth biomarker measurement$331,425
R01 · FY2013 · EB · contact PI
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis$233,139
R01 · FY2012 · EB · contact PI
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis$279,767
R01 · FY2011 · EB · contact PI
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis$291,060
R01 · FY2010 · EB · contact PI
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis$256,926
R01 · FY2009 · EB · contact PI
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis$256,926
R01 · FY2008 · EB · contact PI
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis$262,170
R01 · FY2007 · EB · contact PI
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis$270,000
R01 · FY2006 · EB · contact PI